Gail Darling1, Richard Malthaner2, John Dickie3, Leigh McKnight4, Cindy Nhan4, Amber Hunter4, Robin S McLeod5. 1. Division of Thoracic Surgery, Department of Surgery, University Health Network, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada. Electronic address: gail.darling@uhn.ca. 2. Division of Thoracic Surgery, Department of Surgery, London Health Sciences Centre, Western University, London, Ontario, Canada. 3. Department of Surgery, Lakeridge Health Corporation, Oshawa, Ontario, Canada. 4. Cancer Care Ontario, Toronto, Ontario, Canada. 5. Cancer Care Ontario, Toronto, Ontario, Canada; Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Abstract
BACKGROUND: The aim of this project was to develop a set of quality indicators to assess surgical decision making in the care of patients with non-small cell lung cancer (NSCLC). METHODS: A multidisciplinary Expert Panel of 16 physicians used a modified Delphi process to identify quality indicators that evaluated the processes of care in patients with NSCLC. A systematic review identified potential indicators, which were rated on actionability, validity, usefulness, discriminability, and feasibility in two rounds of questionnaires. The first questionnaire was completed by the Expert Panel and by the larger thoracic surgical community of practice; the second questionnaire was sent to only the Expert Panel. Expert Panel members attended an in-person meeting to review the results of the two questionnaires and to compile the final list of indicators by consensus. RESULTS: From the literature review, 41 potential indicators were identified. An additional 16 indicators were suggested by the Expert Panel: 13 indicators in the two rounds of questionnaires and three after the discussion at the in-person meeting. One further indicator was identified after the in-person meeting. In the end, 17 indicators were chosen from seven domains: preoperative assessment, staging, surgical procedures, pathology, adjuvant therapy, surgical outcomes, and miscellaneous CONCLUSIONS: By use of a modified Delphi process, 17 indicators to assess the quality of processes of surgical care for patients with NSCLC were developed.
BACKGROUND: The aim of this project was to develop a set of quality indicators to assess surgical decision making in the care of patients with non-small cell lung cancer (NSCLC). METHODS: A multidisciplinary Expert Panel of 16 physicians used a modified Delphi process to identify quality indicators that evaluated the processes of care in patients with NSCLC. A systematic review identified potential indicators, which were rated on actionability, validity, usefulness, discriminability, and feasibility in two rounds of questionnaires. The first questionnaire was completed by the Expert Panel and by the larger thoracic surgical community of practice; the second questionnaire was sent to only the Expert Panel. Expert Panel members attended an in-person meeting to review the results of the two questionnaires and to compile the final list of indicators by consensus. RESULTS: From the literature review, 41 potential indicators were identified. An additional 16 indicators were suggested by the Expert Panel: 13 indicators in the two rounds of questionnaires and three after the discussion at the in-person meeting. One further indicator was identified after the in-person meeting. In the end, 17 indicators were chosen from seven domains: preoperative assessment, staging, surgical procedures, pathology, adjuvant therapy, surgical outcomes, and miscellaneous CONCLUSIONS: By use of a modified Delphi process, 17 indicators to assess the quality of processes of surgical care for patients with NSCLC were developed.
Authors: Misa Matsuyama; Mythily Sachchithananthan; Robyn Leonard; Michael Besser; Anna K Nowak; Donna Truran; Claire M Vajdic; John R Zalcberg; Hui K Gan; Craig Gedye; Winny Varikatt; Eng-Siew Koh; Ganessan Kichenadasse; Hao-Wen Sim; Nicholas G Gottardo; Desma Spyridopoulos; Rosalind L Jeffree Journal: Neurooncol Pract Date: 2021-08-31
Authors: Gladys N Honein-AbouHaidar; Terri Stuart-McEwan; Tom Waddell; Alexandra Salvarrey; Jennifer Smylie; Mark J Dobrow; Melissa C Brouwers; Anna R Gagliardi Journal: BMJ Open Date: 2017-02-23 Impact factor: 2.692
Authors: Jilske A Huijben; Eveline J A Wiegers; Nicolette F de Keizer; Andrew I R Maas; David Menon; Ari Ercole; Giuseppe Citerio; Fiona Lecky; Lindsay Wilson; Maryse C Cnossen; Suzanne Polinder; Ewout W Steyerberg; Mathieu van der Jagt; Hester F Lingsma Journal: Crit Care Date: 2019-03-22 Impact factor: 9.097
Authors: Husna Begum; Swarna Vishwanath; Michelle Merenda; Mark Tacey; Nicola Dean; Elisabeth Elder; Marc Mureau; Ron Bezic; Pamela Carter; Rodney D Cooter; Anand Deva; Arul Earnest; Michael Higgs; Howard Klein; Mark Magnusson; Colin Moore; Hinne Rakhorst; Christobel Saunders; Birgit Stark; Ingrid Hopper Journal: Plast Reconstr Surg Glob Open Date: 2019-08-19